Alpha-tocopheryl succinate (α-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil

European Journal of Nutrition

Volumn 46, Issue 1, 2007, Pages 34-43

  Basu, Arpita ^a   Grossie, Bruce ^b   Bennett, Michael ^c   Mills, Nat ^b   Imrhan, Vicky ^b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b TEXAS WOMAN'S UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alpha tocopheryl succinate; Angiogenesis; Prostate cancer; Prostate specific antigen; Xenograft growth

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; SESAME SEED OIL; SOYBEAN OIL; TESTOSTERONE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DIETARY INTAKE; DRUG SCREENING; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTOSTERONE BLOOD LEVEL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SOYBEAN OIL; TESTOSTERONE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAMIN E;

GLYCINE MAX; MUS; MUS MUSCULUS; SESAMUM INDICUM; TOSCANA VIRUS;

EID: 33846809381     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-006-0629-4     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts & Figures 2005 http://www.cancer.org/docroot/STT/stt_0.asp [accessed June 2006]
2. Granado de la OS, Saa RC, Quintas VA (2006) Epidemiological situation of prostate cancer in Spain. Actas Urol Esp 30:574-582
3. Sogani PC, Whitmore WF (1988) Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma. Cancer Treat Res 39:131-145
4. Willis MS, Wians FH (2003) The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta 330:57-83
5. Ripoll EA, Rama BN, Webber MM (1986) Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro. J Urol 136:529-531
6. Israel K, Yu W, Sanders BG, Kline K (2000) Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer 36:90-100
7. Yu A, Somasundar P, Balsubramaniam A, Rose AT, Vona DL (2002) Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. J Surg Res 105:65-68
8. Zhang Y, Ni J, Messing EM, Chang E, Yang CR (2002) Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA 99:7408-7413
9. Zhang M, Altuwaijri S, Yeh S (2004) RRR-α-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene 23:3080-3088
10. Zu K, Ip C (2003) Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res 63:6988-6995
11. Venkateswaran V, Fleshner NE, Sugar LM, Klotz LH (2004) Antioxidants block prostate cancer in Lady transgenic mice. Cancer Res 64:5891-5896
12. Neuzil J (2003) Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumor activity. Br J Cancer 89:1822-1826
13. Malafa MP, Neitzel LT (2000) Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 93:163-170
14. Reeves PG, Nielsen FH, Fahey GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
15. Devaraj S, Jialal I (2000) Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alphatocopherol supplementation. Circulation 102:191-196
16. Hara A, Radin N (1978) Lipid extraction of tissues with a low-toxicity solvent. Annal Biochem 90:420-426
17. Edelstein RA, Krane RJ, Babayan RK, Morenas A, Moreland RB (1995) A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription-polymerase chain reaction assay. Urology 45:597-603
18. Collado B, Gutierrez-Canas I, Rodriguez-Henche N, Prieto JC, Carmena MJ (2004) Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. Regul Pept 119:69-75
19. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T (2000) Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Ther 7:997-1007
20. Jacklin A, Ratledge C, Welham K, Bilko D, Newton CJ (2003) The sesame seed oil constituent, sesamol, induces growth arrest and apoptosis of cancer and cardiovascular cells. Ann N Y Acad Sci 1010:374-380
21. Fleshner N, Fair WR, Huryk R, Heston WDW (1999) Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J Urol 161:1651-1654
22. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ (1999) Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 91:512-523
23. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR (1995) Decreased growth of established human prostate LNCaP tumors in nude mice fed on low-fat diet. J Natl Cancer Inst 87:1456-1461
24. Barnett KT, Fokum FD, Malafa MP (2002) Vitamin E succinate inhibits colon cancer liver metastases. J Surg Res 106:292-298
25. Gilbert VA, Zebrowski EF, Chan AC (1983) Differential effects of mega vitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats. Horm Metab Res 15:320-325
26. Hartman TJ, Dorgan JF, Virtamo J (1999) Association between serum alpha-tocopherol and serum androgens and estrogens in older men. Nutr Cancer 35:10-15
27. Aronson WJ, Tymchuk CN, Elashoff RM (1999) Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr Cancer 35:130-136
28. Thalmann GN, Sikes RA, Chang SM (1996) Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. J Natl Cancer Inst 88:794-801
29. Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schroder A, Erl W, Brunk UT, Coffey RJ, Weber C, Neuzil J (2002) Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res 8:863-869